Boston Common Asset Management LLC Buys 10,154 Shares of AstraZeneca PLC $AZNCF

Boston Common Asset Management LLC grew its position in shares of AstraZeneca PLC (OTCMKTS:AZNCF) by 5.6% during the third quarter, according to its most recent filing with the SEC. The firm owned 192,589 shares of the company’s stock after acquiring an additional 10,154 shares during the period. Boston Common Asset Management LLC’s holdings in AstraZeneca were worth $28,992,000 at the end of the most recent quarter.

AstraZeneca Trading Down 4.5%

OTCMKTS:AZNCF opened at $175.00 on Thursday. The company’s 50 day moving average price is $183.00 and its 200-day moving average price is $166.26. AstraZeneca PLC has a 52 week low of $122.26 and a 52 week high of $192.90.

AstraZeneca Profile

AstraZeneca (OTCMKTS:AZNCF) is a global biopharmaceutical company that focuses on the discovery, development, manufacturing and commercialization of prescription medicines. The company’s research and development efforts are concentrated in three main therapeutic areas: oncology; cardiovascular, renal and metabolism; and respiratory, inflammation and autoimmunity. AstraZeneca’s product portfolio includes targeted therapies for lung and breast cancers, novel agents for heart failure and chronic kidney disease, and inhaled treatments for asthma and chronic obstructive pulmonary disease.

The company was formed in 1999 through the merger of Sweden’s Astra AB and the United Kingdom’s Zeneca Group, creating one of the world’s largest pharmaceutical firms.